Already available in other parts of the world including Japan, Synapse 3D is currently installed in four evaluation sites in the U.S. Physicians at Albert Einstein Medical Center, Philadelphia, Penn., Yale University Medical Center, New Haven, Conn., Margaret Pardee Memorial Hospital, Hendersonville, N.C., and USC Medical Center, Los Angeles, Calif., have been using the product and providing feedback prior to its commercial release which is expected in the first quarter of 2010. One of the evaluators is Meng Law, MD, Director of Neuroradiology, Los Angeles County Hospital and USC Medical Center, who presented findings on his use and review of the product at the International Cancer Imaging Society conference held in early October in Salzburg, Austria.
"In my evaluation, Synapse 3D has proven to be critical in terms of the diagnostic and outcomes value it provides," said Dr. Law. "The PET CT Fusion capabilities, in particular, have performed exceptionally well, and we look forward to using the systems in the future. We have also utilized the advanced MR capabilities for processing diffusion and perfusion data of the brain as well as using the calcium scoring tool for a research project investigating the utility of neurovascular calcium scoring for predicting stroke, "continued Law.
Synapse has undergone significant refinements to support not only the image and information managements needs of radiology and cardiology departments, as well as other critical care departments including oncology, pathology and ophthalmology. The ability to provide both storage and distribution of images throughout the enterprise in both DICOM and web formats is critical to the integrated healthcare network. Additional features including smart forwarding and smart prefetching
|SOURCE FUJIFILM Medical Systems USA, Inc.|
Copyright©2009 PR Newswire.
All rights reserved